KR890000537B1 - Process for preparing 5'guanylic acid through fermentation - Google Patents
Process for preparing 5'guanylic acid through fermentation Download PDFInfo
- Publication number
- KR890000537B1 KR890000537B1 KR1019860005302A KR860005302A KR890000537B1 KR 890000537 B1 KR890000537 B1 KR 890000537B1 KR 1019860005302 A KR1019860005302 A KR 1019860005302A KR 860005302 A KR860005302 A KR 860005302A KR 890000537 B1 KR890000537 B1 KR 890000537B1
- Authority
- KR
- South Korea
- Prior art keywords
- acid
- xanthyl
- strain
- culture
- growth
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/32—Nucleotides having a condensed ring system containing a six-membered ring having two N-atoms in the same ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/13—Brevibacterium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
- C12Y603/04—Other carbon-nitrogen ligases (6.3.4)
- C12Y603/04001—GMP synthase (6.3.4.1)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/84—Brevibacterium
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
내용 없음.No content.
Description
본 발명은 특수한 변이주가 생산하는 크산틸산 아미나제를 이용하여 5'-크산틸산을 5'-구아닐산으로 전환시키는 5'-구아닐산의 제조방법에 관한 것이다. 5'-구아닐산은 정미성을 가지고 있는 핵산계 조미료로 알려져 있는 것으로 종래 5'-크산틸산을 5'-구아닐산으로 전환시키는 방법으로는 크산틸산 아미나제 생산균 배양액에 5'-크산틸산을 첨가하는 방법(일본 특허소 46-39069, 소 47-41557) 전환균주와 5'-크산틸산 생산균주를 동시에 배양하는 혼합배양 방법(일본 특허소 46-39070)등이 알려져 있다. 그러나, 종래 이들 방법은 실제 공업적으로 이용하기에는 다음과 같은 문제점이 있었다.The present invention relates to a method for preparing 5'-guanylic acid by converting 5'-xanthyl acid to 5'-guanylic acid using xantylic acid aminase produced by a special mutant. 5'-guanylic acid is known as a nucleic acid-based seasoning having a taste, and a method of converting 5'-xanthyl acid into 5'-guanylic acid is to add 5'-xanthyl acid to the xanthyl acid aminase-producing cell culture. Methods (Japanese Patent Application No. 46-39069, Small 47-41557) A mixed culture method (Japanese Patent Application No. 46-39070) for simultaneously culturing a converting strain and a 5'-xanthyl acid producing strain is known. However, these methods conventionally had the following problems in actual industrial use.
1 . 5'-크산틸산 배양액으로부터 직접 5'-구아닐산으로 전환시키지 못하고 전환균 배양액에 5'-크산틸산을 첨가하거나, 전환균 배양액으로부터 균체를 회수하여 5'-크산틸산 배양액에 첨가하여 5'-구아닐산을 제조하는 방법을 사용하므로 5'-구아닐산의 제조단가가 높아진다.One . 5'-Xanthyl acid can not be converted directly to 5'-guanylic acid from 5'-xanthyl acid culture medium, or 5'-xanthyl acid can be recovered from converted cell culture medium and added to 5'-xanthyl acid culture solution to 5'-guanylic acid. The production cost of 5'-guanylic acid is increased because of the method for preparing the same.
2 . 5'-구아닐산 이외에 구아노신 2인산 및 구아노신 3인산이 생성되거나 구아닌 또는 구아노신으로 분해되어 구아닌계 물질이 혼합생성되었다.2 . In addition to 5'-guanylic acid, guanosine diphosphate and guanosine triphosphate were produced or decomposed into guanine or guanosine to produce a mixture of guanine-based materials.
본 발명자는 이와 같은 문제점을 해결하기 위해 5'-크산틸산 배양액에 직접 전환균주를 배양하여 5'-구아닐산으로 전환시키는 방법을 연구하여 오던 중 종래의 크산틸산 아마나제 생산균주가 5'-크산틸산 발효액 중 5'-크산틸산 농도가 25-30g/l 이상되면 균생육이 저해되어 크산틸산 아미나제 활성이 낮아져 전환수율이 낮아지고 불필요한 구아닌계 혼합물질이 많이 생성되는 것을 발견하게 되었다.In order to solve this problem, the present inventors have studied a method of culturing a conversion strain directly to 5'-xanthyl acid culture solution and converting it to 5'-guanylic acid, and the conventional xanthyl acid amanase producing strain is 5'-xanthyl acid. When the concentration of 5'-xanthyl acid in the fermentation broth is 25-30 g / l or more, the growth of the fungus is inhibited and the xanthyl acid aminase activity is lowered, resulting in lower conversion yield and generation of unnecessary guanine mixture.
따라서 본 발명자는 고농도의 5'-크산틸산 배양액에서 전환균주의 생육 저해현상을 조사해 본 결과 배양액중 5'-크산틸산이 균생육에 직접 영향을 준다는 것을 알았다.Therefore, the inventors of the present invention investigated the inhibition of growth of the transformed strains in the high concentration of 5'-xanthyl acid, and found that 5'-xanthyl acid in the culture directly affected the growth of the bacteria.
따라서 본 발명자들은 고농도의 5'-크산틸산 함유 배지에서도 생육이 저해받지 않는 5'-크산틸산 내성주를 분리하므로 본 발명을 완성하게 되었다.Therefore, the present inventors have completed the present invention by separating 5'-xanthyl acid-resistant strains which are not inhibited in growth even in a high concentration of 5'-xanthyl acid containing medium.
본 발명의 특수한 변이주브레비박테리움 암모니아게네스 MW-6648(KCTC 8201P)은 브레비박테리움 암모니아게네스 ATCC 6872에서 변이 처리되어 뉴클레오타이드 분해능이 결손되고 데코이닌 내성에 의해서 크산틸산 아미나제 활성이 특별히 강화된 공지의 MW-1672주를 친주로 하여 제변이 처리에 의하여 분리된 것이다.A special variant strain of Brevibacterium ammonia genes MW-6648 (KCTC 8201P) of the present invention is mutated in Brevibacterium ammonia genes ATCC 6872, resulting in a loss of nucleotide resolution and special xanthyl acid aminase activity by decoinine resistance. The modified known strain was isolated from the enhanced known MW-1672 strain.
본 발명의 특수한 변이주 MW-6648을 분리하는 변이처리 및 선별방법은 다음과 같다. MW-1672주를 주 1배지에서 34℃, 12시간 배양한 균체를 0.05M 인산완충액(pH 7.0) 2ml에 현탁시킨 후 500㎍/ml 농도의 N-메칠-N'-니트로-N-니트로소 구아니딘 용액(0.05M 인산완충액에 용해) 2ml를 첨가하여 상온에서 20분간 진탕시킨 후 원심분리 및 세척에 의해서 균체와 변이 유기제를 분리시킨 후 주2의 배지에 평판식균하여 34℃에서 일주일간 배양하였다. 생육이 우수한 균집락을 취하여 주3의 배지에서 34℃, 24시간 진탕배양하여 균생육 농도를 측정하여 비교군(MW-1672 식균)에 비하여 균생육이 우수한 균주를 선별하고, 뉴클레오타이드 분해능이 없고 크산틸산아미나제 활성이 강하며 5'-크산틸산 60mg/ml 농도의 배지에서도 생육이 좋은 본원발명의 균주를 최종 분리하였다.The mutation treatment and screening method for separating the special variant strain MW-6648 of the present invention is as follows. Cells incubated for 12 hours at 34 ° C. in MW-1672 strains were suspended in 2 ml of 0.05 M phosphate buffer (pH 7.0), followed by N-methyl-N'-nitro-N-nitroso at a concentration of 500 µg / ml. 2 ml of guanidine solution (dissolved in 0.05M phosphate buffer solution) was added and shaken at room temperature for 20 minutes, followed by centrifugation and washing to separate cells and mutant organic agents. It was. By taking the excellent bacterial colonies, shaking cultured at 34 ℃ for 24 hours in the medium of week 3, and measuring the bacterial growth concentration, the strains with superior bacterial growth compared to the comparative group (MW-1672 phagocytosis) were selected, and there was no nucleotide degrading ability and no xan The strain of the present invention was finally isolated in a medium having strong thymic acid aminase activity and good growth in a medium having a concentration of 5'-xanthyl acid 60 mg / ml.
주1) 포도당 20g, 황산마그네슘 7수화물 1g, 염화칼슘 2수화물 50mg, 황산망간 1수화물 10mg, 황산아연 7수화물 1mg, 황산제1철 7수화물 10mg, 제1인산카리 1g, 제2인산카리 1g, 황산암모늄 2g, 요소 3g, 치아민염산염 5mg, 판토텐산칼슘 10mg, 니코틴산 5mg, 비오틴 430㎍, 아데닌 20mg, 구아닌 20mg, 한천 20g, 증류수 1l, KOH로 pH 8.0 조절 120℃에서 15분 멸균.Note 1) 20 g of glucose, 1 g of magnesium sulfate monohydrate, 50 mg of calcium chloride dihydrate, 10 mg of manganese sulfate monohydrate, 1 mg of zinc sulfate monohydrate, 10 mg of ferrous sulfate monohydrate, 1 g of ferric phosphate, 1 g of dibasic phosphate, 1 g of sulfuric acid 2 g ammonium, 3 g urea, 5 mg thiamine hydrochloride, 10 mg calcium pantothenate, 5 mg nicotinic acid, 430 µg biotin, 20 mg adenine, 20 mg guanine, 20 g agar, 1 l distilled water, pH 8.0 controlled 15 minutes sterilization at 120 ° C.
주2) 주1 배지에 효모엑스 5g, 5'-크산틸산 60g 첨가.Note 2) Add 5 g of yeast extract and 60 g of 5'-xanthyl acid to the medium of Note 1.
주3) 5'-크산틸산 발효액(5'-크산틸산 농도 53g/l)1l (생산균주 : 브레비박테리윰 암모니아 게네스 MW-4768-6) 포도당 30g, 황산마그네슘 7수화물 1g, 옥수수추출액 5g, 인산 4g, 수산화카리 3g, 황산암모늄 5g, 비오틴 30㎍, 아데닌 20mg, 구아닌 10mg, 115℃에서 15분 멸균.Note 3) 5'-xanthyl acid fermentation broth (5'-xanthyl acid concentration 53g / l) 1 l (Production strain: Brevibacterium ammonia Genes MW-4768-6) 30 g of glucose, 1 g of magnesium sulfate heptahydrate, 5 g of corn extract , 4 g of phosphoric acid, 3 g of hydroxide, 5 g of ammonium sulfate, 30 µg of biotin, 20 mg of adenine, 10 mg of guanine, sterilized for 15 minutes at 115 ° C.
본 발명의 변이주 MW-6648 주가 친주 MW-1672주와 배양 및 생리학적 특성의 차이점은 다음과 같다.The difference between the mutant MW-6648 strain and the parent strain MW-1672 strain of the present invention is as follows.
[표 1]TABLE 1
생리학적 특성비교Comparison of Physiological Characteristics
주4) 영양 요구성 및 당 자화능은 주1의 배지를 기본으로 조사 물질의 제외 및 첨가에 의해 생육여부에 따라 조사되었으며 크산틸산아미나제 활성도는 제널오브 바이오 케미스트리 63권 3호 661페이지(The Journal of Biochemistry Vol 63 No 3. P 661)의 모이드와 마가사닉(H.S Moyed and B magasanik)의 방법에 따라 295mμ에서 비교에 대한 OD 증가로 표시하였다.Note 4) Nutritional requirements and sugar magnetization capacity were investigated by the exclusion and addition of the irradiated material based on the medium of Note 1, and xanthylamide aminase activity was reported in the Journal of Biochemistry Vol. 63, No. 63, No. 6, page 661. According to the method of the Journal of Biochemistry Vol 63 No 3. P 661) and the method of HS Moyed and B magasanik was expressed as an increase in OD for comparison at 295mμ.
[표 2]TABLE 2
5'-크산틸산 첨가배지 및 5'-크산틸산 발효액에서 생육비교Growth Growth in 5'-Xanthyl Acid Addition Medium and 5'-Xanthyl Acid Fermentation Broth
주5) +++ : 생육양호, ++ : 생육보통, ± : 거의 생육않음, - : 생육않음 사용 배지는 주 1 및 2, 34℃에서 72시간 배양하여 생육도를 조사하였다.Note 5) +++: growth and growth, ++: normal growth, ±: almost no growth,-: no growth The medium was incubated at 1 and 2, 34 ℃ for 72 hours to examine the growth.
[표 3]TABLE 3
액체 배양시 각 영양 물질에 따른 생육도 비교Comparison of Growth Rate by Nutrient Substances in Liquid Culture
주6) 대조균은 주1의 배지(한천제외) 특성조사는 각 물질을 주1의 배지에서 제외하였을 때 생육도를 610㎛ 에서 흡광도를 측정하였다. 배양조건 : 500ml 플라스크에 50ml 분주 34℃에서 48시간 진탕배양.Note 6) The control strain of the culture medium (except agar) of week 1 measured the absorbance at 610 ㎛ when the growth of each material was excluded from the medium of week 1. Culture conditions: 50ml shake in a 500ml flask cultured for 48 hours at 34 ℃.
위 표 1, 2, 3의 생리적 비교 실험에서 볼 수 있는 바와같이 본원 발명의 특수한 변이주의 생리적 성질은 친주 MW-1672주가 영양 요구성에 있어 아데닌ㆍ비오틴 필수 및 치아민 염산염에 생육이 촉진되고, 당 자화성이 과당 포도당 만을 자화하는데 비하여 변이주 MW-6648의 특이한 점은 영양 요구성에서 비오틴필수, 아데닌, 구아닌, 판토텐산 칼슘에 특히 생육이 촉진되어 생리학적 및 배양학적 특성이 공지의 MW-1672주와 명확히 구분되며, 특히 5'-크산틸산에 내성을 가지므로 고농도의 5'-크산틸산 배양액에서도 생육에 저해받지 않고 높은 크산틸산 아미나제 활성을 가지고 있어 5'-크산틸산 배양액에서 직접 5'-구아닐산으로 진화시키는 5'-구아닐산 제조방법에 적합한 우수한 변이주로 판단된다.As can be seen in the physiological comparison experiments of Tables 1, 2, and 3 above, the physiological properties of the special mutant strains of the present invention promote the growth of adenine / biotin essential and chiamine hydrochloride in nutritional needs of the parent strain MW-1672. The peculiarity of the mutant strain MW-6648 is that Mars magnetizes only fructose glucose, but its physiological and culture characteristics are clearly distinguished from those of known MW-1672 strains because of its nutritional requirement, which promotes the growth of biotin essential, adenine, guanine and calcium pantothenate. In particular, since it is resistant to 5'-xanthyl acid, it has high xanthyl acid aminase activity without being inhibited in growth even in the high concentration of 5'-xanthyl acid culture, so it can be directly converted into 5'-guanylic acid from 5'-xanthyl acid culture. It is judged to be an excellent variant suitable for the evolving 5'-guanylic acid production method.
본 발명의 균주의 배지는 탄소원으로 포도당, 과당, 만노스 및 이들을 구성하고 있는 다당류의 가수분해물질을 사용할 수 있고 질소원으로서는 암모니아 및 암모니움염 요소등을 사용한다. 그의 균의 생리적 성질에 따라 각종 무기물, 및 유기 영양물을 첨가하고 특히 효모엑스, 미트엑스, 옥수수 침지액, 펩톤 등이 유효하다.As the medium of the strain of the present invention, hydrolyzate of glucose, fructose, mannose, and polysaccharides constituting them can be used as the carbon source, and ammonia and ammonia salt urea are used as the nitrogen source. According to the physiological properties of the bacteria, various inorganic and organic nutrients are added, and yeast extract, meat extract, corn steep liquor, peptone and the like are effective.
본 발명의 변이주는 위의 영양분을 첨가한 수용액 즉, 종래의 미생물 배지 뿐만 아니라, 고농도의 5'-크산틸산 발효액에 위 영양분을 첨가한 배지에서 생육하며 크산틸산 아미나제를 생산하여 배지중의 5'-크산틸산을 5'-구아닐산으로 효율 좋게 전환시킨다. 배양 종료 후 이미 알려진 이온교환수지 흡착용리 방법에 의하여 생산된 5'-구아닐산을 회수한다.The mutant strain of the present invention is grown in an aqueous solution containing the above nutrients, that is, a conventional microbial medium, as well as a medium in which the above nutrients are added to a high concentration of 5'-xanthyl acid fermentation broth, and the xanthanate aminase is produced in the medium. '-Xanthyl acid is efficiently converted to 5'-guanylic acid. After the incubation, 5'-guanylic acid produced by a known ion exchange resin adsorption elution method is recovered.
본 발명의 변이주를 이용하여 5'-구아닐산을 생산하는 상세한 방법을 다음 실시예에서 기재하고 있으나 본원이 실시예에 한정되는 것은 아니다.A detailed method for producing 5'-guanylic acid using the mutant strain of the present invention is described in the following examples, but the present application is not limited to the examples.
[실시예 1]Example 1
사용균주 : 본 발명의 특수한 변이주 MW-6648Use strain: special variant strain MW-6648 of the present invention
종 배 양 : 포도당 40g, 인산 제1카리 3g, 인산 제2카리 3g, 펩톤 5g, 옥수수 침출액 10g, 황산암모늄 6g, 요소 3g, 염화칼슘 2 수화물 0.1g, 황산제1철 7수화물 10mg, 황산망간 1 수화물 10mg, 황산아연 7 수화물 1mg, 비오틴 50㎍, 니코틴산 5mg, 판토텐산칼슘 10mg, 아데닌 30mg, 구아닌 30mg, 증류수 1l, 5N-KOH로 pH 7.6으로 조절하여 2l 진량플라스크에 300ml 분주한 후 120℃에서 20분간 가압 멸균한다. 종균을 1 백금이 식균한 후 32℃에서 24시간 진탕 배양하여 종배양액을 제조한다.Species culture: Glucose 40g, 3g first phosphate, 3g second phosphate, 5g peptone, 5g corn leachate, 6g ammonium sulfate, 3g urea, 0.1g calcium chloride dihydrate, 10mg ferrous sulfate heptahydrate, 1 manganese sulfate Hydrate 10mg, Zinc Sulfate Heptahydrate 1mg, Biotin 50㎍, Nicotinic Acid 5mg, Pantothenate Calcium 10mg, Adenine 30mg, Guanine 30mg, Distilled Water 1l, 5N-KOH Autoclave for minutes. After the seedlings were inoculated with 1 platinum, shaking culture was performed at 32 ° C. for 24 hours to prepare a seed culture solution.
생산배지 조성 및 배양방법Production medium composition and culture method
5'-크산틸산 배양액(5'-크산틸산 62mg/ml 함유) 5l를 80-90℃에서 가열 살균한 후 주 7배지를 첨가한 후 상기와 같이 종배양한 종배양액 300ml를 접종하여 30-35℃에서 pH 6.8-7.2, 통기량 0.5-1VVM, 600rpM으로 20시간 배양한 후 주 8의 배지를 첨가하여 계속 배양한다. 배양개시 후 35시간이 되면 배양 온도를 43-45℃, pH 7.4-7.6, 통기량 0.5 VVM으로 조절하고 주 9배지를 첨가한다. 이후 배양시간 2-3시간 간격으로 황산마그네슘 0.1-0.05%되게 2회 첨가하며, 배양개시 43시간에 발효를 종료했다. 최종발효액 중 5'-구아닐산 농도는 48.5mg/ml였으며 5'-구아닐산 이외 구아닌계 혼합물질, 5'-크산틸산은 미량 존재했다. 균체를 제거한 배양액 2l를 강산성 양이온 교환수지 및 강염기성 음이온 교환수지에 통액시켜 상법에 따라 5'-구아닐산을 회수 농축하여 조결정 89.4g을 얻었다.5 l of 5'-xanthyl acid culture (containing 62 mg / ml of 5'-xanthyl acid) was heated and sterilized at 80-90 ° C, followed by the addition of 7 medium a week, and then inoculated with 300 ml of the seed culture cultured as described above. After incubation for 20 hours at pH 6.8-7.2, aeration 0.5-1VVM, 600rpm, the medium of week 8 is added and the culture is continued. At 35 hours after incubation, the incubation temperature is adjusted to 43-45 ° C., pH 7.4-7.6, aeration 0.5 VVM, and 9 times a week is added. Thereafter, the culture time was added twice so that the magnesium sulfate was 0.1-0.05% at intervals of 2-3 hours, and the fermentation was terminated at 43 hours from the start of the culture. The concentration of 5'-guanylic acid in the final fermentation solution was 48.5 mg / ml, and there were trace amounts of guanine-based mixture and 5'-xanthyl acid in addition to 5'-guanylic acid. 2 l of the culture medium from which the cells were removed was passed through a strong acid cation exchange resin and a strong base anion exchange resin, and 5'-guanylic acid was recovered and concentrated according to a conventional method to obtain 89.4 g of crude crystals.
주7) 포도당 300g, 인산 8g, 수산화카리 7g, 황산마그네슘 7수화물 4, 판토텐산칼슘 10mg, 니코틴산 10mg, 아데닌ㆍ구아닌 각 10mg, 증류수 400ml 120℃에서 20분 멸균.Note 7) Sterilized for 20 minutes at 300 g of glucose, 8 g of phosphoric acid, 7 g of hydroxide hydroxide, 4 mg of magnesium sulfate heptahydrate, 10 mg of calcium pantothenate, 10 mg of nicotinic acid, 10 mg each of adenine and guanine, and 400 ml of distilled water for 20 minutes.
주8) 포도당 400g을 증류수에 용해 500ml 되게 한다. 120℃에서 20분 멸균.Note 8) 400 g of glucose is dissolved in distilled water to make 500 ml. Sterilize at 120 ° C. for 20 minutes.
주9) 포도당 180g, 인산제3나트륨 12 수화물 20g, 황산마그네슘 7 수화물 10g, 알킬디메칠벤질 암모늄클로라이드 10g을 증류수에 용해하여 300ml 되게 한다. 120℃에서 20분 멸균.Note 9) Dissolve 180 g of glucose, 20 g of trisodium phosphate 12 hydrate, 10 g of magnesium sulfate heptahydrate, and 10 g of alkyl dimethylbenzyl ammonium chloride in distilled water to make 300 ml. Sterilize at 120 ° C. for 20 minutes.
주10) 발효조는 N.B.S.14l를 사용하였으며 5'-구아닐산 및 5'-크산틸산, 구아닌계 혼합물 분석은 HPLC를 사용하였다.Note 10) N.B.S.14l was used for the fermenter, and HPLC was used for 5'-guanylic acid, 5'-xanthyl acid and guanine mixture analysis.
주11) 5'-크산틸산 발효액 5'-크산틸산 생산 균주는 브테비 박테리움 암모니아 게네스 MW-4768-8을 이용하여 공지의 방법에 의해 배양하였다.Note 11) 5'-xanthyl acid fermentation broth 5'-xanthyl acid production strain was cultured by a well-known method using the Btevi bacterium ammonia Genes MW-4768-8.
[실시예 2]Example 2
포도당 대신 전분 당화액을 사용하여 실시예 1에 준하여 배양하였으며 최종 발효액의 5'-구아닐산 농도는 32.4mg/ml 였다. 5'-구아닐산 이외의 5'-크산틸산, 구아노신 3 인산, 구아노신 2 인산, 구아닌 및 구아노신은 거의 검출되지 않았다.It was cultured according to Example 1 using starch saccharification instead of glucose, and the concentration of 5'-guanylic acid of the final fermentation was 32.4 mg / ml. 5'-Xanthyl acid, guanosine triphosphate, guanosine diphosphate, guanine and guanosine other than 5'-guanylic acid were hardly detected.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019860005302A KR890000537B1 (en) | 1986-07-01 | 1986-07-01 | Process for preparing 5'guanylic acid through fermentation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019860005302A KR890000537B1 (en) | 1986-07-01 | 1986-07-01 | Process for preparing 5'guanylic acid through fermentation |
Publications (2)
Publication Number | Publication Date |
---|---|
KR880001822A KR880001822A (en) | 1988-04-27 |
KR890000537B1 true KR890000537B1 (en) | 1989-03-20 |
Family
ID=19250857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019860005302A KR890000537B1 (en) | 1986-07-01 | 1986-07-01 | Process for preparing 5'guanylic acid through fermentation |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR890000537B1 (en) |
-
1986
- 1986-07-01 KR KR1019860005302A patent/KR890000537B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR880001822A (en) | 1988-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0217159B2 (en) | ||
US2978384A (en) | Method for the production of 1-glutamic acid | |
EP0647717A1 (en) | Method of producing vitamin B12 | |
KR890000537B1 (en) | Process for preparing 5'guanylic acid through fermentation | |
EP0076516B1 (en) | Method for fermentative production of l-proline | |
CN102586383B (en) | Process for preparing cytidine diphosphate choline | |
KR890000539B1 (en) | Process for preparing 5'-guanylic acid using microorganism | |
KR850001940B1 (en) | Process for preparing 5'-guanilic acid by micro organism | |
KR830001259B1 (en) | Method for producing L-glutamine by microorganisms | |
US3238110A (en) | Method for producing 5-amino-4-imidazolecarboxamide riboside | |
KR800000476B1 (en) | Method for preparation of adenosin by micro-organism | |
KR0146493B1 (en) | Process for producing l-alanine by fermentation | |
US3725201A (en) | Manufacture of uridine-5-diphosphoglucuronic acid | |
KR890001127B1 (en) | Producing method for oligo-fructose | |
US3328261A (en) | Method for the fermentative production of 5-amino-4-imidazole carboxamide ribotide | |
JP3006907B2 (en) | Method for producing L-alanine by fermentation method | |
US4430429A (en) | Production of vitamin B12 -activity substances | |
KR950005923B1 (en) | Preparation method of 5'-inosine acid by cultivation | |
KR890000540B1 (en) | Process for preparing 5'-ksantiliyc acid | |
KR890000538B1 (en) | Process for preparing 5-inosinic acid using microorganism | |
JPH01144989A (en) | Production of colominic acid | |
KR970002251B1 (en) | MICROORGANISM PRODUCING 5óÑ-XANTHYL ACID | |
KR970002252B1 (en) | MICROORGANISM PRODUCING 5óÑ-XANTHYL ACID | |
KR860000248B1 (en) | Method for producing 5'xantil acid by microorganism | |
KR970000587B1 (en) | Microorganism producing gmp |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
G160 | Decision to publish patent application | ||
O035 | Opposition [patent]: request for opposition | ||
E701 | Decision to grant or registration of patent right | ||
O073 | Decision to grant registration after opposition [patent]: decision to grant registration | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20000318 Year of fee payment: 12 |
|
LAPS | Lapse due to unpaid annual fee |